N. Goebels et al., Repertoire dynamics of autoreactive T cells in multiple sclerosis patientsand healthy subjects - Epitope spreading versus clonal persistence, BRAIN, 123, 2000, pp. 508-518
Autoantigen-specific T-lymphocytes are present in patients with autoimmune
disease and in normal subjects. Little is currently known about the tempora
l variation (dynamics) of the immune repertoire of these autoreactive T cel
ls, We analysed the long-term variation of the immune repertoire of T cells
specific for myelin basic protein (MBP) in five untreated patients with mu
ltiple sclerosis and four normal control subjects over a mean observation p
eriod of 6 years, MBP-specific CD4(+) T-cell lines were selected with purif
ied human MBP, and their epitope specificity was mapped with overlapping sy
nthetic peptides, Three distinct patterns of repertoire development were ob
served, (i) Two patients and three control subjects maintained a broad epit
ope response with fluctuations over time, (ii) Two patients initially showe
d a focused response that broadened over the course of 6 years; this findin
g could be described as intramolecular epitope spreading, (iii) In one pati
ent and one control subject, a strikingly focused response, which was direc
ted to a cluster of nested epitopes in the MBP region 83-102, persisted ove
r time, T-cell receptor V beta sequence analysis allowed us to trace indivi
dual clones of MBP-specific T cells for up to 7 years in the peripheral cir
culation in four of the five patients and three of the four controls, sugge
sting that the long-term persistence of MBP-specific T-cell clones is a com
mon feature of the T-cell repertoire not unique to multiple sclerosis, The
persisting MBP-specific T-cell clones were not detectable in the blood of o
ne of the patients by complementarity-determining region (CDR)-3 spectratyp
ing, indicating that their frequency does not exceed 1 in 5000 T cells, The
temporal characteristics of the MBP-specific T-cell repertoire described h
ere are relevant to therapeutic strategies targeting autoantigen-specific T
cells in multiple sclerosis and other autoimmune diseases.